Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SPironolactONe for the Maintenance of Sinus Rhythm in Hypertensive Patients With Atrial Fibrillation and Preserved Left Ventricular Ejection Fraction (SPONSoR Study).

NCT06204640 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT06204640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06204640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SPironolactONe for the Maintenance of Sinus Rhythm in Hypertensive Patients With Atrial Fibrillation and Preserved Left Ventricular Ejection Fraction (SPONSoR Study).
Lead sponsor
University Hospital, Caen
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 1, 2024
Completion date
January 1, 2029
Enrollment
580 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation recurrent